Sana Biotechnology Inc - ESG Rating & Company Profile powered by AI
If you are employed by Sana Biotechnology Inc and you wish to licence your ESG aseessment, please get in touch. Detailed ESG assessment of Sana Biotechnology Inc can be reached by registering for free. This ESG assessment for Sana Biotechnology Inc represents its reporting of the UN Sustainable Development Goals.
Sana Biotechnology Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.2; made up of an environmental score of 2.7, social score of 1.1 and governance score of 2.7.
2.2
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1529 | Slang Worldwide Inc | 2.3 | Medium |
1529 | Vanda Pharmaceuticals Inc | 2.3 | Medium |
1551 | Sana Biotechnology Inc | 2.2 | Medium |
1551 | Brawn Biotech Ltd | 2.2 | Medium |
1551 | Pangaea Oncology SA | 2.2 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sana Biotechnology Inc have an accelerator or VC vehicle to help deliver innovation?
Does Sana Biotechnology Inc disclose current and historical energy intensity?
Does Sana Biotechnology Inc report the average age of the workforce?
Does Sana Biotechnology Inc reference operational or capital allocation in relation to climate change?
Does Sana Biotechnology Inc disclose its ethnicity pay gap?
Does Sana Biotechnology Inc disclose cybersecurity risks?
Does Sana Biotechnology Inc offer flexible work?
Does Sana Biotechnology Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sana Biotechnology Inc disclose the number of employees in R&D functions?
Does Sana Biotechnology Inc conduct supply chain audits?
Does Sana Biotechnology Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sana Biotechnology Inc conduct 360 degree staff reviews?
Does Sana Biotechnology Inc disclose the individual responsible for D&I?
Does Sana Biotechnology Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sana Biotechnology Inc disclose current and / or historical scope 2 emissions?
Does Sana Biotechnology Inc disclose water use targets?
Does Sana Biotechnology Inc have careers partnerships with academic institutions?
Did Sana Biotechnology Inc have a product recall in the last two years?
Does Sana Biotechnology Inc disclose incidents of discrimination?
Does Sana Biotechnology Inc allow for Work Councils/Collective Agreements to be formed?
Has Sana Biotechnology Inc issued a profit warning in the past 24 months?
Does Sana Biotechnology Inc disclose parental leave metrics?
Does Sana Biotechnology Inc disclose climate scenario or pathway analysis?
Does Sana Biotechnology Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sana Biotechnology Inc disclose the pay ratio of women to men?
Does Sana Biotechnology Inc support suppliers with sustainability related research and development?
Does Sana Biotechnology Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sana Biotechnology Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sana Biotechnology Inc involved in embryonic stem cell research?
Does Sana Biotechnology Inc disclose GHG and Air Emissions intensity?
Does Sana Biotechnology Inc disclose its waste policy?
Does Sana Biotechnology Inc report according to TCFD requirements?
Does Sana Biotechnology Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sana Biotechnology Inc disclose energy use targets?
Does Sana Biotechnology Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sana Biotechnology Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Sana Biotechnology Inc
These potential risks are based on the size, segment and geographies of the company.
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.